RGEN (Repligen Corp.) Prakiraan volume dodolan
The projected sales chart for Repligen Corporation (RGEN) on GURU.Markets displays 0.81, illustrating the level of this metric. Growth is supported by patent protection and stringent FDA oversight. Innovative filtration systems are accelerating the release of gene therapies, while the critical importance of biopharmaceutical consumables offsets the business's narrow niche specialization, ensuring stable demand for Repligen Corporation (RGEN) products.
Repligen Inc. - rincian analitis lan metrik utama (RGEN)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Repligen Corporation|RGEN - Kewajiban jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Repligen Corp|RGEN - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Repligen|RGEN - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Repligen|Indikator likuiditas cepet repligen.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
RGEN - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Repligen Corporation|RGEN - Periode bali modal bisnis|Rega marang bathi mangsa ngarep repligen.com|RGEN - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Repligen Corporation|RGEN - Bathi operasional sadurunge amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Repligen|RGEN - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan repligen.com|RGEN - Owah-owahan bathi resik saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Repligen Corporation
- data dodolan lan asil:
Analisis kabeh metrik perusahaan:RGEN Repligen
Due to stringent equipment certification in biopharmaceutical production lines, Repligen Corporation (RGEN) possesses an exceptional market barrier that protects its revenues from competition. By analyzing the organization's projected sales volume, an investor sees the result of continuous discounting of future cash flows, accounting for inflationary risks and logistics, which allows for an assessment of the business model's resilience prior to the publication of official financial statements.
Pesaing langsung
Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Dodolan mangsa ngarep perusahaan Qiagen Group|Prakiraan pendapatan perusahaan Ionis Pharma IONS|Avidity Corp (RNA) - Volume dodolan sing dikarepake perusahaan|CRSP - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Twist Bioscience Corp TWST|Prakiraan volume dodolan TXG|Prakiraan volume dodolan intelliatx.com (NTLA)|Stoke Therapeutics - Volume dodolan mangsa ngarep perusahaan|BioLife Solutions Inc (BLFS) - Volume dodolan sing dikarepake perusahaan|wavelifesciences.com - Prakiraan volume dodolan|Maze Therapeutics Corp (MAZE) - Volume dodolan mangsa ngarep perusahaan|SION: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PRME|Prakiraan pendapatan perusahaan Taysha Gene Therapies|Prakiraan pendapatan perusahaan QURE (uniQure)|Prakiraan pendapatan perusahaan MeiraGTx (MGTX)|REGENXBIO Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Solid Biosciences SLDB|OCGN - Volume dodolan mangsa ngarep perusahaan|pacb.com - Prakiraan volume dodolan|Benitec (BNTC) - Volume dodolan mangsa ngarep perusahaan|DSGN: Prakiraan volume dodolan|RCKT - Dodolan mangsa ngarep perusahaan|FDMT: Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan LXEO (lexeotx.com)|Prakiraan pendapatan perusahaan Korro Bio Inc. (KRRO)|Prakiraan volume pendapatan perusahaan EDIT|Prakiraan volume dodolan SLN (Silence Therapeutics PLC)|Pendapatan mangsa ngarep perusahaan PRQR|CDXS - Prakiraan pendapatan perusahaan|SGMO (Sangamo Therapeutics) - Prakiraan pendapatan perusahaan|NAUT: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan MGX|DTIL (precisionbiosciences.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GBIO (Generation Bio Co.)|Prakiraan pendapatan perusahaan Boundless Bio (BOLD)|Exicure - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IMNN (imunon.com)|Dodolan mangsa ngarep perusahaan Phio Pharmaceuticals (PHIO)|MBIO: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Prakiraan pendapatan perusahaan|APDN - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BLUE|Prakiraan volume dodolan immunoprecise.com|Prakiraan volume dodolan OMGA|Dodolan mangsa ngarep perusahaan Singular Genomics Corp|Regulus Therapeutics - Volume dodolan mangsa ngarep perusahaan|SYRS (Syros Pharmaceuticals) - Pendapatan sing dikarepake perusahaan|Telesis Bio Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan TCON (TRACON Pharmaceuticals Inc.)|UBX: Prakiraan volume dodolan
